LOS ANGELES: Los Angeles and Google have struck a partnership to track canopy density in the huge metropolis to determine which neighbourhoods need more trees as a means of fighting extreme temperatures. Vegetation, notably tree canopy coverage, plays a key role in offering the kind of relief that ......
The chief executives of the largest U.S. airlines made a fresh plea for Congress to pass a new round of federal payroll aid this year to meet the logistical challenges of distributing a COVID-19 vaccine, according to a letter to Congressional leaders sent on Wednesday.
With bitcoin surging to the cusp of its 2017 all-time high, backers are hoping fewer frenzied retail investors means less chance of a crash this time around.
Twitter Inc will slow down the rollout of tweets that disappear after 24 hours, a day after it launched the feature worldwide, in order to fix performance and stability issues, the company's support team said in a tweet on Wednesday.
Judy Shelton, Republican President Donald Trump's contentious pick to fill a vacant seat at the Federal Reserve, faced a more difficult road to confirmation as the U.S. Senate adjourned on Wednesday until after Thanksgiving.
Nvidia Corp shares declined nearly 3per cent on Wednesday after company executives said data center chip sales would fall slightly in the fourth quarter.
Asian stocks followed Wall Street's sharp selloff on Thursday as concerns about rising coronavirus infections and new shutdowns in major U.S. cities hosed down earlier investor enthusiasm about COVID-19 vaccine developments.
Shares of Tesla surged 10per cent to end near a record high on Wednesday, extending a two day rally after it was announced the electric car maker will join the S&P 500.
Electric vehicle startup Rivian, which is backed by Amazon and Ford Motor Co , on Wednesday said it plans to follow up its first two products, a full-size pickup and SUV, with smaller models targeted at China and Europe where it may eventually build some vehicles.
Results from Moderna’s and Pfizer’s coronavirus vaccine candidates show why pursuing more than one option gives the world the best chance to eliminate the pandemic, say two immunology experts.
